HOME >> MEDICINE >> NEWS
Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit

Corautus Genetics Inc. (NASDAQ:VEGF) announced today the publication of the two year follow-up results of the Corautus' earlier Phase I study of VEGF-2 in patients with severe angina. In this trial, Vascular Endothelial Growth Factor-2 (VEGF-2), in the form of "naked" plasmid DNA (a non-viral delivery vector) was delivered in defined doses by direct injection into the heart muscle. Results of the follow-up study, as reported by the investigators in the current issue of the Journal of Interventional Cardiology (JOIC) (Vol. 18, No. 1, pp. 27 31, 2005), demonstrate prolonged clinical benefit as measured by improvement of patients' angina two years following treatment (p < 0.05) with no reported complications directly related to the gene therapy procedure. The Journal article and full publication are available on line at www.blackwellpublishing.com/joic .

Corautus' technology is currently being tested in a randomized, double-blinded, dose-ranging and placebo-controlled Phase IIb clinical trial known as GENASIS ("Genetic Angiogenic Stimulation Investigational Study"), which will enroll 404 patients with Class III or IV angina that are not suitable candidates for traditional revascularization procedures. The GENASIS trial will be conducted in approximately 25 cardiac medical centers throughout the United States. In the GENASIS trial, defined doses of VEGF-2 in the form of "naked" plasmid DNA are delivered to diseased heart muscle tissue via the Boston Scientific Corporation (NYSE: BSX) Stiletto(TM) endocardial direct injection catheter system. The injection procedure is performed by a cardiologist in a standard cardiac laboratory. Corautus expects to complete patient enrollment of the Phase IIb trial around the end of 2005.

Dr. Douglas W. Losordo, the national Principal Investigator for the GENASIS trial and Chief of Cardiovascular Research at Caritas St. Elizabeth's Medical Center in Bosto
'"/>

Contact: Justin Jackson
jjackson@burnsmc.com
212-213-0006
Burns McClellan
8-Mar-2005


Page: 1 2 3 4 5

Related medicine news :

1. Many children are undervaccinated or have delayed vaccinations in their first 2 years of life
2. 14-year study finds that quitting smoking adds years to life
3. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
4. Cumulative trauma in adulthood can worsen health in later years
5. Malnutrition in early years leads to low IQ and later antisocial behavior, USC study finds
6. Vioxx should have been withdrawn 4 years ago
7. Cancer burden seen even many years after diagnosis
8. Scientists meet to review Envisat results after two and a half years of operations
9. Study finds lung transplants increase survival of cystic fibrosis patients by more than four years
10. Full recovery after cell transplantation for treating leukemia or lymphoma can take 3-5 years
11. Full recovery after cell transplantation for treating leukemia or lymphoma can take 3-5 years

Post Your Comments:
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) ... for detecting lung cancer now have more information to help ... study finds that low-dose CT scans pick up significantly more ... long history of smoking are at high risk for lung ... But doctors have to consider the potential harm of radiation ...
(Date:5/23/2013)... According to a new market report "Service ... Data Management (SDM); Telecom Application Server; Service Creation Environment; ... 2018)", published by MarketsandMarkets, the SDP Market is expected ... of 9.15% from 2013 to 2018. , Browse:, ... 84 Figures , 189 Pages and ...
(Date:5/23/2013)... May 23, 2013 DRE, Inc. is ... as a solution to upgrade older model DRE ... the entire lighting system. , DRE and BFW ... DRE or BFW halogen headlights to LED with DRE’s ... C3 LED Conversion Kit provides a bright, clean and ...
(Date:5/23/2013)... Located at 22343 La Palma Ave. #125, ... its Grand Opening Family Fun Charity event on May 11, ... and physical fitness. Sponsored by many different vendors like Chick-fil-a ... filled Grand Opening featured mini boot camp sessions and raffled ... the Yorba Linda fitness center has to offer. ...
Breaking Medicine News(10 mins):Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3
(Date:5/23/2013)... 2013  Net Medical Xpress Solutions, Inc., (OTC QB: ... the company has signed a letter of intent to ... Huntsville, AL . MedTel Solutions is ... and recruitment of telemedicine physicians. Consideration for the acquisition ... which is expected by June 30, 2013. ...
(Date:5/23/2013)... Md. , May 23, 2013  BioElectronics Corporation ... consumer medical devices, comments on the FDA panel meeting ... Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting was ... MD , USA.  The focus of the meeting ... the panel to focus solely on the application of ...
(Date:5/23/2013)... Israel Brain Technologies (IBT) has announced ... Israel,s 1 st International Brain Technology Conference, ... in Tel Aviv , recently ranked ... world by the Wall Street Journal and the ... will showcase the latest breakthroughs in neuroscience and brain technology ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
Cached News: